Search results

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

The release of the Oppenheimer film, the story of the director of the Manhattan Project,  has prompted many people to go online and search for an explanation of the difference between fission and fusion, two fundamental scientific concepts.

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

Frequently asked questions about ANSTO for the community.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.  

ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.

See details of previously published customer updates from our Health products team. 

Explore ANSTO's range of publications and reports available for the public.

The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

ANSTO offers a broad range of programs and services to various industries and customers. Many of these services, including the Australian Nuclear Medicine Traceability program, are supported by online customer portals.

INVAP, the Argentinian advanced nuclear technology company, who designed and constructed the Open Pool Lightwater Reactor (OPAL) for ANSTO to replace the HIFAR reactor is celebrating 50 years of operations with the visit of a group of INVAP executives to ANSTO to celebrate their achievements and discuss future collaborations.

ANSTO recently re-started the OPAL Reactor after a six-month shutdown for essential maintenance and the installation of an upgraded facility.